Researchers at the Weizmann Institute of Science announced Tuesday they have discovered, in a world first, that specialized immune cells known as memory B cells can recognize and attack ovarian cancer tumors.
The findings pave the way for the development of vaccines and therapies that harness immune memory to fight cancer.
“If we suggest that there are memory cells, antibody-forming cells that remember the tumor, and we can activate them with a vaccine, then we can make cancer vaccines that stimulate these cells,” said Shulman, who supervised the research. “I’m very excited. It’s a new idea, a totally new approach to vaccines for cancer patients.”
Read more on The Times of Israel.
No hay comentarios:
Publicar un comentario
Nota: solo los miembros de este blog pueden publicar comentarios.